There is one clinical trial.
Evaluate the cardiovascular and metabolic properties of MANP in subjects with HTN and MS according to rs5068 genotypes
MANP in Hypertension and Metabolic Syndrome Evaluate the cardiovascular and metabolic properties of MANP in subjects with HTN and MS according to rs5068 genotypes cardiovascular outcome.
Description: systolic blood pressure
Measure: cardiovascular outcome Time: 24 hoursDescription: cGMP plasma levels
Measure: second messenger Time: 24 hoursDescription: glycerol and non-esterified fatty acids (NEFA) plasma levels
Measure: metabolic outcome Time: 24 hoursDescription: diastolic blood pressure
Measure: secondary cardiovascular outcome Time: 24 hoursDescription: adiponectin plasma levels
Measure: secondary metabolic outcome Time: 24 hours